Although Vangl1 may compensate for loss of Vangl2 in some contexts [18], Vangl1 transcript is not significantly altered in Vangl2fl/fl/NDL mammary tumors relative to Vangl2+/+/NDL tumors (Additional file 4: Fig. S8c). This evidence concerns the gene VANGL2 and breast cancer.